W. Siegrist et al., INTERACTIONS OF ALPHA-MELANOTROPIN AND AGOUTI ON B16 MELANOMA-CELLS -EVIDENCE FOR INVERSE AGONISM OF AGOUTI, Journal of receptor and signal transduction research, 17(1-3), 1997, pp. 75-98
alpha-Melanocyte-stimulating hormone (alpha-MSH, alpha-melanotropin) a
nd agouti control the switch between eumelanin and pheomelanin synthes
is in mammalian melanocytes. Here we investigated interactions between
alpha-MSH, agouti protein, cAMP elevating agents and phorbol ester on
mouse B16 melanoma cells. Agouti (K-d 3.7 nmol/l) and alpha-MSH (K-d
2.3 nmol/l) had similar affinities to the MCl melanocortin receptor. B
oth alpha-MSH and agouti induced MCl receptor down-regulation. Agouti
antagonized melanogenesis induced by alpha-MSH, forskolin, cholera tox
in (CT), and pertussis toxin (PT). It also reduced the constitutive me
lanin formation of long-term cultures. Cell proliferation was inhibite
d by agouti (43% at 100 nM). This effect was reversed by alpha-MSH, fo
rskolin, or CT. B16-G4F. cells, a cell variant that lacks the MCl rece
ptor, did not respond to agouti. From these results we conclude that a
gouti shows the characteristics of an inverse agonist acting through t
he MCl receptor.